会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • BIOMARKERS FOR DIFFERENTIATING MELANOMA FROM BENIGN NEVUS IN THE SKIN
    • 生物标志物用于鉴别皮肤良性黑色素瘤中的黑色素瘤
    • WO2012040168A3
    • 2012-07-12
    • PCT/US2011052305
    • 2011-09-20
    • ADVANCED CELL DIAGNOSTICS INCMA XIAO-JUNWU XINGYONGLUO YULING
    • MA XIAO-JUNWU XINGYONGLUO YULING
    • C12Q1/68
    • C12Q1/6886C12Q2600/112C12Q2600/158C12Q2600/16
    • Disclosed is a method for diagnosing melanoma in a human subject, as well as a method for providing a prognosis to a human subject who is at risk of developing melanoma recurrence, and a method for determining the stage of melanoma in a human subject, comprising the step of determining the level of expression of phosphatase and actin regulator 1 (PHACTR1) gene, or fragments thereof, either alone or in combination with the level of expression of secreted integrin-binding phosphoprotein (SPP1), preferentially expressed antigen in melanoma (PRAME), growth differentiation factor 15 (GDF15), and chemokine C-X-C motif ligand 10 (CXCL10) genes. Further, the invention relates to a diagnostic kit, comprising at least one substance for detection of the expression of PHACTR1, or fragments thereof, either alone or in combination with the detection of SPP1, PRAME, GDF15, and CXCL10, for the diagnosis or prognosis of melanoma.
    • 本发明公开了一种用于诊断人类受试者中黑素瘤的方法,以及一种用于对处于发展中的黑素瘤复发风险的人类受试者提供预后的方法以及一种用于确定受试者中黑素瘤阶段的方法,该方法包括 步骤:单独测定磷酸酶和肌动蛋白调节因子1(PHACTR1)基因或其片段的表达水平,或者与分泌的整联蛋白结合磷蛋白(SPP1)的表达水平组合,优先在黑素瘤中表达的抗原(PRAME) ,生长分化因子15(GDF15)和趋化因子CXC基序配体10(CXCL10)基因。 此外,本发明涉及诊断试剂盒,其包含至少一种用于检测PHACTR1或其片段的表达的至少一种物质,其单独或与检测SPP1,PRAME,GDF15和CXCL10组合用于诊断或预后 黑色素瘤。
    • 3. 发明申请
    • BIOMARKERS FOR DIFFERENTIATING MELANOMA FROM BENIGN NEVUS IN THE SKIN
    • 用于从皮肤中的新陈代谢来分化MELANOMA的生物标记物
    • WO2012040168A2
    • 2012-03-29
    • PCT/US2011/052305
    • 2011-09-20
    • ADVANCED CELL DIAGNOSTICS, INC.MA, Xiao-JunWU, XingyongLUO, Yuling
    • MA, Xiao-JunWU, XingyongLUO, Yuling
    • C12Q1/68
    • C12Q1/6886C12Q2600/112C12Q2600/158C12Q2600/16
    • Disclosed is a method for diagnosing melanoma in a human subject, as well as a method for providing a prognosis to a human subject who is at risk of developing melanoma recurrence, and a method for determining the stage of melanoma in a human subject, comprising the step of determining the level of expression of phosphatase and actin regulator 1 (PHACTR1) gene, or fragments thereof, either alone or in combination with the level of expression of secreted integrin-binding phosphoprotein (SPP1), preferentially expressed antigen in melanoma (PRAME), growth differentiation factor 15 (GDF15), and chemokine C-X-C motif ligand 10 (CXCL10) genes. Further, the invention relates to a diagnostic kit, comprising at least one substance for detection of the expression of PHACTR1, or fragments thereof, either alone or in combination with the detection of SPP1, PRAME, GDF15, and CXCL10, for the diagnosis or prognosis of melanoma.
    • 公开了一种用于诊断人类受试者中的黑素瘤的方法,以及用于对患有黑色素瘤复发风险的人类受试者提供预后的方法,以及用于确定人类受试者的黑色素瘤阶段的方法,包括 单独或与分泌的整联蛋白结合磷蛋白(SPP1)的表达水平相结合的磷酸酶和肌动蛋白调节剂1(PHACTR1)基因或其片段的表达水平的测定步骤,优先表达黑素瘤抗原(PRAME) ,生长分化因子15(GDF15)和趋化因子CXC基序配体10(CXCL10)基因。 此外,本发明涉及一种诊断试剂盒,其包含至少一种用于检测PHACTR1或其片段的表达的物质,或者与检测SPP1,PRAME,GDF15和CXCL10一起或与SPP1,PRAME,GDF15和CXCL10的检测结合用于诊断或预后 的黑色素瘤。